Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire E Dearden

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Seminars in Hematology|March 22, 2006
Role of single-agent purine analogues in therapy of peripheral T-cell lymphomasClaire E Dearden
Clinical Lymphoma & Myeloma|September 26, 2009
T-cell prolymphocytic leukemiaClaire E Dearden
British Medical Bulletin|October 19, 2007
Role of antibody therapy in lymphoid malignanciesClaire E Dearden
Medical Oncology (Northwood, London, England)|April 29, 2006
T-cell prolymphocytic leukemiaClaire E Dearden
Expert Review of Anticancer Therapy|April 12, 2008
Alemtuzumab in the treatment of chronic lymphocytic lymphomaKevin Boyd, Claire E Dearden
Best Practice & Research. Clinical Haematology|September 26, 2006
Alemtuzumab in T-cell lymphoproliferative disordersClaire E Dearden, Estella Matutes
Best Practice & Research. Clinical Haematology|March 15, 2017
Epidemiology and environmental aspects of marginal zone lymphomasPriya Sriskandarajah, Claire E Dearden
Hematology/Oncology Clinics of North America|January 9, 2004
Peripheral T-cell lymphomas: diagnosis and managementClaire E Dearden, Francine M Foss
Leukemia & Lymphoma|May 24, 2011
Long-term results for pentostatin and cladribine treatment of hairy cell leukemiaClaire E Dearden, Monica Else, Daniel Catovsky
Best Practice & Research. Clinical Haematology|November 29, 2015
Long-term follow-up after purine analogue therapy in hairy cell leukaemiaMonica Else, Claire E Dearden, Daniel Catovsky
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Seminars in Hematology|March 22, 2006
Role of single-agent purine analogues in therapy of peripheral T-cell lymphomasClaire E Dearden
Clinical Lymphoma & Myeloma|September 26, 2009
T-cell prolymphocytic leukemiaClaire E Dearden
British Medical Bulletin|October 19, 2007
Role of antibody therapy in lymphoid malignanciesClaire E Dearden
Medical Oncology (Northwood, London, England)|April 29, 2006
T-cell prolymphocytic leukemiaClaire E Dearden
Expert Review of Anticancer Therapy|April 12, 2008
Alemtuzumab in the treatment of chronic lymphocytic lymphomaKevin Boyd, Claire E Dearden
Best Practice & Research. Clinical Haematology|September 26, 2006
Alemtuzumab in T-cell lymphoproliferative disordersClaire E Dearden, Estella Matutes
Best Practice & Research. Clinical Haematology|March 15, 2017
Epidemiology and environmental aspects of marginal zone lymphomasPriya Sriskandarajah, Claire E Dearden
Hematology/Oncology Clinics of North America|January 9, 2004
Peripheral T-cell lymphomas: diagnosis and managementClaire E Dearden, Francine M Foss
Leukemia & Lymphoma|May 24, 2011
Long-term results for pentostatin and cladribine treatment of hairy cell leukemiaClaire E Dearden, Monica Else, Daniel Catovsky
Best Practice & Research. Clinical Haematology|November 29, 2015
Long-term follow-up after purine analogue therapy in hairy cell leukaemiaMonica Else, Claire E Dearden, Daniel Catovsky
Pageof 3